for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Smith & Nephew plc

SN.L

Latest Trade

1,358.00GBp

Change

-6.50(-0.48%)

Volume

709,570

Today's Range

1,340.00

 - 

1,371.00

52 Week Range

1,055.01

 - 

1,802.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
1,364.50
Open
1,358.50
Volume
709,570
3M AVG Volume
30.37
Today's High
1,371.00
Today's Low
1,340.00
52 Week High
1,802.00
52 Week Low
1,055.01
Shares Out (MIL)
878.88
Market Cap (MIL)
11,992.38
Forward P/E
21.11
Dividend (Yield %)
1.97

Next Event

Dividend For SN. - 23.1000 USX

Latest Developments

More

Smith + Nephew Says Impact Of COVID-19 Is Likely To Continue During First Half Of 2021

Smith & Nephew Sees Decline In FY Underlying Revenue

Smith & Nephew Says FY Outlook Remains Withdrawn

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Smith & Nephew plc

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Industry

Medical Equipment & Supplies

Contact Info

Building 5, Croxley Park, Hatters Lane

WD18 8YE

United Kingdom

+44.20.74017646

http://www.smith-nephew.com/

Executive Leadership

Roberto Quarta

Non-Executive Independent Chairman of the Board

Roland D. Diggelmann

Chief Executive Officer, Executive Director

Anne-Francoise Michele Nesmes

Chief Financial Officer, Executive Director

Ian Melling

Interim Chief Financial Officer

Brad Cannon

President - Sports Medicine & ENT

Key Stats

2.31 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

4.9K

2019

5.1K

2020

4.6K

2021(E)

5.3K
EPS (USD)

2018

1.010

2019

1.020

2020

0.650

2021(E)

0.914
Price To Earnings (TTM)
37.39
Price To Sales (TTM)
3.67
Price To Book (MRQ)
3.16
Price To Cash Flow (TTM)
16.57
Total Debt To Equity (MRQ)
69.90
LT Debt To Equity (MRQ)
63.52
Return on Investment (TTM)
5.25
Return on Equity (TTM)
4.41

Latest News

Latest News

Smith & Nephew revenue slide to slow in third quarter

Medical prosthetics maker Smith & Nephew Plc <SN.L> expects its decline in underlying revenue to be just 4% in the third quarter of this year, down from almost 30% in the previous three months when it was suffering heavily from the impact of coronavirus lockdowns and a halt...

Supreme Court to consider all sides’ cert petitions in Arthrex patent-law case

When the U.S. Supreme Court meets next week for its first conference since the summer recess, the agenda will include a decision so controversial that all parties have asked the justices to review it.

Nivea-maker Beiersdorf downbeat for 2020

Nivea-maker Beiersdorf <BEIG.DE> reported a 20% drop in first-half operating profit on Thursday and predicted a fall in sales and profitability for the full year as both its consumer business and adhesives unit suffer in the coronavirus pandemic.

BRIEF-Smith+Nephew CEO Says July So Far Looking Bit Better Than June - Interview

* CEO SAYS HAVEN’T CLOSED JULY OUT YET, BUT MONTH SO FAR LOOKING A BIT BETTER THAN JUNE - INTERVIEW

Nivea-maker Beiersdorf sales fell 10.7% in first half

Nivea-maker Beiersdorf <BEIG.DE> said on Monday it had seen a 10.7% fall in first-half sales as both its consumer business and adhesives unit were hard hit by the coronavirus pandemic.

BRIEF-Smith & Nephew Expects Q2 Underlying Rev Decline Of Around 29%

* SMITH & NEPHEW - EXPECTS A Q2 UNDERLYING(1) REVENUE DECLINE OF AROUND -29%

BRIEF-Smith+Nephew's Regeneten Bioinductive Implant Receives CE Mark

* SMITH+NEPHEW'S REVOLUTIONARY REGENETEN™ BIOINDUCTIVE IMPLANT RECEIVES CE MARK Source text for Eikon: Further company coverage:

BRIEF-Smith & Nephew Announces U.S. Launch Of Tula System For Placement Of Ear Tubes

* SMITH & NEPHEW - ANNOUNCES US LAUNCH OF TULA SYSTEM FOR PLACEMENT OF EAR TUBES

BRIEF-Smith & Nephew Reports Launch Of New Journey II Unicompartmental Knee System

* SMITH & NEPHEW - ANNOUNCES LAUNCH OF ITS NEW JOURNEY II UNICOMPARTMENTAL KNEE (UK) SYSTEM

BRIEF-Smith+Nephew April sales nearly halve; Q1 sales drop 7.6%

* SMITH & NEPHEW - Q1 REVENUE $1,134 MILLION (2019: $1,202 MILLION), DOWN -7.6% ON AN UNDERLYING BASIS, CONSISTENT WITH 30 MARCH TRADING UPDATE

Smith & Nephew can't limit hip implant plaintiffs' lawyers' doctor contacts

A federal judge has rejected Smith & Nephew's request to restrict lawyers for plaintiffs who claim they were injured by defective hip implants from speaking with their clients' doctors outside of the presence of the medical device maker's attorneys.

BRIEF-Smith & Nephew Bob White To Join As Non-Executive Director

* MEDTRONIC'S BOB WHITE JOINS SMITH+NEPHEW'S BOARD AS NON-EXECUTIVE DIRECTOR Source text for Eikon: Further company coverage:

BRIEF-Smith & Nephew Says AGM Will Be Held At Sheethanger Common, Hertfordshire

* SMITH & NEPHEW - AGM WILL NOW BE HELD AT SHEETHANGER COMMON, FELDEN LANE, FELDEN, HEMEL HEMPSTEAD, HERTFORDSHIRE Source text for Eikon: Further company coverage:

Nivea-maker Beiersdorf scraps 2020 outlook due to coronavirus crisis

Nivea-maker Beiersdorf <BEIG.DE> on Thursday scrapped its 2020 outlook due to the coronavirus pandemic, and also released preliminary first-quarter sales that showed a 3.6% fall from a year earlier.

BRIEF-PIRC Recommends Smith & Nephew Shareholders To Vote Against Resolution On Remuneration Policy

* PROXY ADVISORY FIRM PIRC RECOMMENDS SMITH & NEPHEW SHAREHOLDERS TO VOTE AGAINST RESOLUTION ON REMUNERATION POLICY Further company coverage:

BRIEF-Smith & Nephew PLC Withdraws FY Outlook

* TOO EARLY TO DETERMINE CONSEQUENT IMPACT OF COVID-19 PANDEMIC ON OUR BUSINESS.

Nivea-maker Beiersdorf starts producing disinfectants

Nivea-maker Beiersdorf has started serial production of medical grade disinfectants to support the fight against the coronavirus pandemic in Europe, the German consumer goods firm said on Thursday.

Nivea-maker Beiersdorf starts producing disinfectants

Nivea-maker Beiersdorf has started serial production of medical grade disinfectants to support the fight against the coronavirus pandemic in Europe, the German consumer goods firm said on Thursday.

BRIEF-Smith & Nephew Says Graham Baker To Step Down From His Position As CFO

* GRAHAM BAKER WILL STEP DOWN FROM BOARD AND HIS POSITION AS CHIEF FINANCIAL OFFICER

BRIEF-Smith+Nephew Announces Us Launch Of PICO 14 Single Use Negative Pressure Wound Therapy System For Use On High Risk Surgical Patients

* SMITH+NEPHEW ANNOUNCES US LAUNCH OF PICO 14 SINGLE USE NEGATIVE PRESSURE WOUND THERAPY SYSTEM FOR USE ON HIGH RISK SURGICAL PATIENTS Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up